Hamostaseologie

Papers
(The TQCC of Hamostaseologie is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-07-01 to 2024-07-01.)
ArticleCitations
Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH151
Factor XI as a Target for New Anticoagulants52
Platelets and COVID-1949
Head, Neck, and Abdominopelvic Septic Thrombophlebitis: Current Evidence and Challenges in Diagnosis and Treatment30
Thrombophilia, Thrombosis and Thromboprophylaxis in Pregnancy: For What and in Whom?26
Platelet Shape Changes during Thrombus Formation: Role of Actin-Based Protrusions26
Ovarian Vein Thrombosis: A Narrative Review21
Procoagulant Platelets: Mechanisms of Generation and Action18
Management of Disseminated Intravascular Coagulation in Acute Leukemias17
Effects and Side Effects of Platelet Transfusion14
Erratum: Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH14
The Evolution of Hemophilia Care: Clinical and Laboratory Advances, Opportunities, and Challenges14
From Routine to Research Laboratory: Strategies for the Diagnosis of Congenital Fibrinogen Disorders14
COVID-19 and Cardiac Arrhythmias13
Anti-inflammatory Strategies in Atherosclerosis13
Insights into the Molecular Genetic of Hemophilia A and Hemophilia B: The Relevance of Genetic Testing in Routine Clinical Practice13
Challenges in Detecting Clinically Relevant Heparin-Induced Thrombocytopenia Antibodies12
COVID-19 Coagulopathy with Superior Mesenteric Vein Thrombosis Complicated by an Ischaemic Bowel12
Prevention and Management of Thrombosis in BCR/ABL-Negative Myeloproliferative Neoplasms12
Understanding and Preventing Placenta-Mediated Pregnancy Complications11
In Silico Hemostasis Modeling and Prediction11
Use of Anticoagulants in Patients with Pulmonary Hypertension11
Role of Platelet Cytoskeleton in Platelet Biomechanics: Current and Emerging Methodologies and Their Potential Relevance for the Investigation of Inherited Platelet Disorders11
Screening for Occult Cancer in Patients with Venous Thromboembolism: Past, Present, and Future10
Trauma-Induced Coagulopathy and Massive Bleeding: Current Hemostatic Concepts and Treatment Strategies10
A Review of FXIa Inhibition as a Novel Target for Anticoagulation10
Management of Antithrombin Deficiency in Pregnancy10
Pulmonary Hypertension and COVID-199
Consensus Recommendations for Intramuscular COVID-19 Vaccination in Patients with Hemophilia9
Functional Roles of the von Willebrand Factor Propeptide9
COVID-19 and Myocarditis: Findings from Cardiac Magnetic Resonance Imaging and Endomyocardial Biopsies9
How to Differentiate Recurrent Deep Vein Thrombosis from Postthrombotic Syndrome8
Bleeding Risk Assessment in Patients with Venous Thromboembolism8
Molecular Profiling of Liver Sinusoidal Endothelial Cells in Comparison to Hepatocytes: Reflection on Which Cell Type Should Be the Target for Gene Therapy8
Cardiac and Cerebral Arterial Complications of Lemierre Syndrome: Results from a Systematic Review and Individual Patient Data Meta-analysis8
Mechanism, Functions, and Diagnostic Relevance of FXII Activation by Foreign Surfaces8
Current and Future Perspectives on ADAMTS13 and Thrombotic Thrombocytopenic Purpura8
New Developments in the Pathophysiology and Management of Primary Immune Thrombocytopenia8
When and How to Combine Antiplatelet and Anticoagulant Drugs?8
An Update on Laboratory Diagnostics in Haemophilia A and B8
Anticoagulation in Pediatric Patients7
What about Platelet Function in Platelet Concentrates?7
Diagnosis of Platelet Function Disorders: A Challenge for Laboratories7
Extended Half-Life Factor VIII/Factor IX Products: Assay Discrepancies and Implications for Hemophilia Management7
Anticoagulation in Critically Ill Adults during Extracorporeal Circulation7
Usefulness of Thrombin Generation7
Fine-Tuning of Platelet Responses by Serine/Threonine Protein Kinases and Phosphatases—Just the Beginning7
COVID-19 and the Incidence of Acute Myocardial Injury6
Measuring Fibrinolysis6
Interventional Treatment Options in Children with Extracranial Vascular Malformations6
Laboratory Techniques Used to Diagnose Constitutional Platelet Dysfunction6
Venous Thrombosis and SARS-CoV-26
Microvascular Skin Manifestations Caused by COVID-196
Can We Measure the Individual Prothrombotic or Prohemorrhagic Tendency by Global Coagulation Tests?6
Gentherapie der Hämophilie: Empfehlung der Gesellschaft für Thrombose- und Hämostaseforschung (GTH)6
Critical Bleeding in Acquired Hemophilia A: Bypassing Agents or Recombinant Porcine Factor VIII?6
Anticoagulation Therapy in Cancer Patients with Thrombosis in the Outpatient Sector of Germany (The CERTIFICAT Initiative)—German Practice of Anticoagulation Therapy of Cancer Patients with Thrombosis5
Nonfactor Therapies: New Approaches to Prophylactic Treatment of Haemophilia5
How to Capture the Bleeding Phenotype in FXI-Deficient Patients5
Global Coagulation Testing in Acute Care Medicine: Back to Bedside?5
Platelets and Matrix Metalloproteinases: A Bidirectional Interaction with Multiple Pathophysiologic Implications5
Bleeding Issues in Women Under Oral Anticoagulation5
Emicizumab for All Pediatric Patients with Severe Hemophilia A5
How the COVID-19 Pandemic Impacts Lives of Life Scientists5
Platelets in Myocardial Ischemia/Reperfusion Injury5
Translating Laboratory Tests into Clinical Practice: A Conceptual Framework4
Assessment and Monitoring of Coagulation in Patients with COVID-19: A Review of Current Literature4
Flow Cytometric Assessment of AKT Signaling in Platelet Activation: An Alternative Diagnostic Tool for Small Volumes of Blood4
Pathogenic Aspects of Inherited Platelet Disorders4
Do miRNAs Have a Role in Platelet Function Regulation?4
Laboratory Assessment of Coagulation Factor XIII4
Screening for Cancer in Patients with Acute Venous Thromboembolic Disease4
Analysis of an Inherited Dysfibrinogenemia Pedigree Associated with a Heterozygous Mutation in the FGA Gene4
Insights from the Hereditary Thrombotic Thrombocytopenic Purpura Registry: Discussion of Key Findings Based on Individual Cases from Switzerland4
Thromboinflammation as a Driver of Venous Thromboembolism4
New Opportunities for Diagnosis and Prognosis of Stroke: The Benefits of Across Border Approaches3
Diagnosing Inherited Platelet Disorders: Modalities and Consequences3
Venous Thromboembolism Issues in Women3
COVID-19 Presented with Deep Vein Thrombosis in a Patient with Paroxysmal Nocturnal Haemoglobinuria3
Transgender Medicine and Risk of Venous Thromboembolism3
Anticoagulation in Patients with Platelet Disorders3
An Update on Safe Anticoagulation3
Thrombosis and Dissection of the Abdominal Arteries Associated with Infarcts of Solid Organs in a Patient with COVID-19: A Novel Clinical Entity3
Potentials of Endothelial Colony-Forming Cells: Applications in Hemostasis and Thrombosis Disorders, from Unveiling Disease Pathophysiology to Cell Therapy3
Immune Plasma for the Treatment of COVID-19: Lessons Learned so far3
COVID-19: SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia3
Cerebral Venous Thrombosis: What's New?3
Communication in Healthcare: Global challenges in the 21st Century3
Emicizumab for the Treatment of Acquired Hemophilia A: Consensus Recommendations from the GTH-AHA Working Group3
Effect of DDAVP on Platelet Activation and Platelet-Derived Microparticle Generation3
Markers of Hereditary Thrombophilia with Unclear Significance3
Origins, Development, Current Challenges and Future Directions with Activated Prothrombin Complex Concentrate for the Treatment of Patients with Congenital Haemophilia with Inhibitors3
Novel Likely Pathogenic Variant in the A3 Domain of von Willebrand Factor Leading to a Collagen-Binding Defect3
Massive Hemorrhage: The Role of Whole Blood Viscoelastic Assays3
GTH 2021: simply online … worth experiencing3
0.032885074615479